{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:26:19Z","timestamp":1779888379826,"version":"3.53.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09J18105-003"],"award-info":[{"award-number":["2018ZX09J18105-003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09711003-013-002"],"award-info":[{"award-number":["2018ZX09711003-013-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["A\/Shanghai\/2\/2013 (H7N9"],"award-info":[{"award-number":["A\/Shanghai\/2\/2013 (H7N9"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673339"],"award-info":[{"award-number":["81673339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773619"],"award-info":[{"award-number":["81773619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.061","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:22:14Z","timestamp":1604150534000},"page":"7938-7948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus"],"prefix":"10.1016","volume":"38","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-8473","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.vaccine.2020.10.061_b0005","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2015.07.026","article-title":"Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus","volume":"33","author":"Pushko","year":"2015","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2020.10.061_b0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.10.061_b0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijid.2015.01.013","article-title":"Isolation and characteristic analysis of a novel strain H7N9 of avian influenza virus A from a patient with influenza-like symptoms in China","volume":"33","author":"Chen","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.061_b0020","doi-asserted-by":"crossref","first-page":"e00502","DOI":"10.1128\/mSphere.00502-17","article-title":"Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans","volume":"2","author":"Stadlbauer","year":"2017","journal-title":"mSphere"},{"issue":"50","key":"10.1016\/j.vaccine.2020.10.061_b0025","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1016\/j.vaccine.2014.09.070","article-title":"Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine","volume":"32","author":"Babu","year":"2014","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2020.10.061_b0030","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.061_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.061_b0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/infdis\/jiu528","article-title":"A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model","volume":"211","author":"Kreijtz","year":"2015","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2020.10.061_b0045","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1128\/JVI.01085-13","article-title":"Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin","volume":"87","author":"Goff","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.061_b0050","first-page":"287","article-title":"Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus","volume":"6","author":"Li","year":"2015","journal-title":"J Vaccines Vaccin"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.061_b0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vaccine.2009.10.048","article-title":"Development of a simple and high-yielding fed-batch process for the production of influenza vaccines","volume":"28","author":"Meghrous","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.061_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81771-7","article-title":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation","volume":"95","author":"Chen","year":"1998","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.061_b0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CVI.00085-16","article-title":"Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms","volume":"23","author":"McCraw","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"5796","key":"10.1016\/j.vaccine.2020.10.061_b0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.1422456112","article-title":"Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus","volume":"112","author":"Pu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/160.2.191","article-title":"Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs","volume":"160","author":"Katz","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.061_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"issue":"7456","key":"10.1016\/j.vaccine.2020.10.061_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vaccine.2020.10.061_b0100","doi-asserted-by":"crossref","first-page":"11735","DOI":"10.1128\/JVI.01084-12","article-title":"Glycan-Dependent Immunogenicity of Recombinant Soluble Trimeric Hemagglutinin","volume":"86","author":"de Vries","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.061_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2010.03.047","article-title":"The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity","volume":"403","author":"de Vries","year":"2010","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2020.10.061_b0110","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1007\/s00216-013-6988-9","article-title":"N-glycosylamine-mediated isotope labeling for mass spectrometry-based quantitative analysis of N-linked glycans","volume":"405","author":"Gong","year":"2013","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11033-011-0809-z","article-title":"Expression, purification and characterization of low-glycosylation influenza neuraminidase in alpha-1,6-mannosyltransferase defective Pichia pastoris","volume":"39","author":"Yang","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.061_b0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/glycob\/cwh104","article-title":"Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose","volume":"14","author":"Bobrowicz","year":"2004","journal-title":"Glycobiology"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2020.10.061_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(01)02676-X","article-title":"Use of HDEL-tagged Trichoderma reesei mannosyl oligosaccharide 1,2-alpha-D-mannosidase for N-glycan engineering in Pichia pastoris","volume":"503","author":"Callewaert","year":"2001","journal-title":"FEBS Lett"},{"issue":"41","key":"10.1016\/j.vaccine.2020.10.061_b0130","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1074\/jbc.273.41.26298","article-title":"Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae","volume":"273","author":"Chiba","year":"1998","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.061_b0135","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0931263100","article-title":"Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris","volume":"100","author":"Choi","year":"2003","journal-title":"PNAS"},{"issue":"5637","key":"10.1016\/j.vaccine.2020.10.061_b0140","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1088166","article-title":"Production of complex human glycoproteins in yeast","volume":"301","author":"Hamilton","year":"2003","journal-title":"Science"},{"issue":"5792","key":"10.1016\/j.vaccine.2020.10.061_b0145","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1126\/science.1130256","article-title":"Humanization of yeast to produce complex terminally sialylated glycoproteins","volume":"313","author":"Hamilton","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nbt1178","article-title":"Optimization of humanized IgGs in glycoengineered Pichia pastoris","volume":"24","author":"Li","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.061_b0155","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/AEM.70.5.2639-2646.2004","article-title":"In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris","volume":"70","author":"Vervecken","year":"2004","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.061_b0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jbiotec.2011.11.002","article-title":"Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris","volume":"157","author":"Nett","year":"2012","journal-title":"J Biotechnol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.10.061_b0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jim.2011.10.003","article-title":"A novel fragment of antigen binding (Fab) surface display platform using glycoengineered Pichia pastoris","volume":"375","author":"Lin","year":"2012","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.061_b0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.copbio.2007.09.001","article-title":"Glycosylation engineering in yeast: the advent of fully humanized yeast","volume":"18","author":"Hamilton","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.061_b0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.copbio.2006.06.010","article-title":"Challenges in therapeutic glycoprotein production","volume":"17","author":"Sethuraman","year":"2006","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.061_b0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1872-2075(07)60056-9","article-title":"A Pichia pastoris with alpha-1,6-mannosyltransferasesdeletion and its use in the expression of HSA\/GM-CSF chimera","volume":"23","author":"Wang","year":"2007","journal-title":"Chin J Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.061_b0185","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.03253-14","article-title":"Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface","volume":"89","author":"Alvarado-Facundo","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.10.061_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/370606","article-title":"Association of influenza virus proteins with membrane rafts","volume":"2011","author":"Veit","year":"2011","journal-title":"Adv Virol"},{"key":"10.1016\/j.vaccine.2020.10.061_b0195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.061_b0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0966-842X(99)01460-2","article-title":"Understanding influenza virus pathogenicity","volume":"7","author":"Garten","year":"1999","journal-title":"Trends Microbiol"},{"issue":"15","key":"10.1016\/j.vaccine.2020.10.061_b0205","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1128\/JVI.79.15.10003-10012.2005","article-title":"Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: Protein characterization, incorporation into infectious influenza viruses, and antigenicity","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"issue":"33","key":"10.1016\/j.vaccine.2020.10.061_b0210","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2018.07.004","article-title":"H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice","volume":"36","author":"Qin","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.061_b0215","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/protein\/6.8.883","article-title":"Analysis of RNA phage fr coat protein assembly by insertion, deletion and substitution mutagenesis","volume":"6","author":"Pushko","year":"1993","journal-title":"Protein Eng"},{"issue":"41","key":"10.1016\/j.vaccine.2020.10.061_b0220","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1407808111","article-title":"H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection","volume":"111","author":"Liang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jbiotec.2009.06.016","article-title":"Disruption of the OCH1 and MNN1 genes decrease N-glycosylation on glycoprotein expressed in Kluyveromyces lactis","volume":"143","author":"Liu","year":"2009","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.061_b0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jviromet.2012.07.026","article-title":"Recombinant haemagglutinin protein of highly pathogenic avian influenza A (H5N1) virus expressed in Pichia pastoris elicits a neutralizing antibody response in mice","volume":"187","author":"Murugan","year":"2013","journal-title":"J Virol Methods"},{"issue":"13","key":"10.1016\/j.vaccine.2020.10.061_b0235","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/JVI.00452-16","article-title":"Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro","volume":"90","author":"Liu","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.10.061_b0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2016.08.001","article-title":"An avian influenza H5N1 virus vaccine candidate based on the extracellular domain produced in yeast system as subviral particles protects chickens from lethal challenge","volume":"133","author":"Pietrzak","year":"2016","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.061_b0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14712598.4.5.709","article-title":"The role of cell culture vaccines in the control of the next influenza pandemic","volume":"4","author":"Audsley","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.061_b0250","first-page":"24","article-title":"Cell-based protein vaccines for influenza","volume":"7","author":"Cox","year":"2005","journal-title":"Curr Opin Mol Ther"},{"issue":"18","key":"10.1016\/j.vaccine.2020.10.061_b0255","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMp058068","article-title":"Preparing for the next pandemic","volume":"352","author":"Osterholm","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.061_b0260","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/nbt1204-1487","article-title":"Next generation flu vaccine boosted by Chiron debacle","volume":"22","author":"Sheridan","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.061_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128982","article-title":"Identification of Influenza A\/PR\/8\/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.10.061_b0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/1743-422X-8-524","article-title":"Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice","volume":"8","author":"Athmaram","year":"2011","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0275","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biotechadv.2014.01.004","article-title":"Multi-stage continuous high cell density culture systems: a review","volume":"32","author":"Chang","year":"2014","journal-title":"Biotechnol Adv"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vaccines6020031","article-title":"Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy","volume":"6","author":"Gallagher","year":"2018","journal-title":"Vaccines"},{"issue":"7554","key":"10.1016\/j.vaccine.2020.10.061_b0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature14348","article-title":"Dissemination, divergence and establishment of H7N9 influenza viruses in China","volume":"522","author":"Lam","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.061_b0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.061_b0295","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00705-016-2968-7","article-title":"Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins","volume":"161","author":"Jiang","year":"2016","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.061_b0300","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13567-018-0576-0","article-title":"Pathobiology of Tennessee 2017 H7N9 low and high pathogenicity avian influenza viruses in commercial broiler breeders and specific pathogen free layer chickens","volume":"49","author":"Bertran","year":"2018","journal-title":"Vet Res"},{"issue":"6277","key":"10.1016\/j.vaccine.2020.10.061_b0305","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science"},{"issue":"6165","key":"10.1016\/j.vaccine.2020.10.061_b0310","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.vaccine.2020.10.061_b0315","doi-asserted-by":"crossref","first-page":"E7151","DOI":"10.1073\/pnas.1615939113","article-title":"Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2020.10.061_b0320","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.061_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011694","article-title":"An influenza A\/H1N1\/2009 hemagglutinin vaccine produced in Escherichia coli","volume":"5","author":"Aguilar-Yanez","year":"2010","journal-title":"PLoS ONE"},{"issue":"39","key":"10.1016\/j.vaccine.2020.10.061_b0330","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1016\/j.vaccine.2016.07.051","article-title":"Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine","volume":"34","author":"Gupta","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:39:29Z","timestamp":1778539169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":66,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313700"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}